Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-08-17
1991-12-24
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31405
Patent
active
050753290
ABSTRACT:
Indolepyruvic acid shows an inhibitory activity with respect to the degenerative action by oxygen free radical which are responsible for a number of pathologic conditions in various peripheral tissues. The compound can find application in miocardiopathies, inflammations, circulatory shock, arteriosclerosis, and cardiac ischemia.
REFERENCES:
Chem Abst. 111:23387f (1989), De Luca et al.
Free Radicals in Medicine and Biology, 10/79.
Free Radicals in Molecular Biology, Aging, and Disease, vol. 27.
The Importance of Free Radicals and Catalytic Metal Ions in Human Diseases, 1985.
DeLuca Giovanna
DiStazio Giovanni
Materazzi Mario
Politi Vincenzo
Fay Zohreh A.
Polifarma S.p.A.
Waddell Frederick E.
LandOfFree
Use of 3-indolepyruvic acid as a pharmaceutical agent for the in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3-indolepyruvic acid as a pharmaceutical agent for the in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3-indolepyruvic acid as a pharmaceutical agent for the in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-43774